gluco-pyranosylphospho-lipid
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2013 (NCT01717950)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gluco-pyranosylphospho-lipid
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03910972 | Phase 1/Phase 2 (Phase 2) | Jun 30, 2019 | Baylor University, George Washington University, Makerere University |
| NCT01717950 | Phase 1 | Sep 1, 2013 | Baylor University, George Washington University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Baylor University | Academic/Hospital | 2 | 2 | 2 | 2013 |
| George Washington University | Academic/Hospital | 2 | 0 | 2 | 2013 |
| Makerere University | Academic/Hospital | 1 | 0 | 1 | 2019 |
3 organizations
Page 1 / 1